Linking a peptide with a small-molecule ligand for the serum protein transthyretin ensures half-life extension without diminishing potency through protection against proteases and decreasing glomerular filtration.
- Sravan C Penchala
- Mark R Miller
- Mamoun M Alhamadsheh